KCTD7 Antikörper (N-Term)
Kurzübersicht für KCTD7 Antikörper (N-Term) (ABIN633658)
Target
Alle KCTD7 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- KCTD7 antibody was raised against the N terminal of KCTD7
-
Aufreinigung
- Affinity purified
-
Immunogen
- KCTD7 antibody was raised using the N terminal of KCTD7 corresponding to a region with amino acids VVVTGREPDSRRQDGAMSSSDAEDDFLEPATPTATQAGHALPLLPQEFPE
-
-
-
-
Applikationshinweise
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
KCTD7 Blocking Peptide, (ABIN5614311), is also available for use as a blocking control in assays to test for specificity of this KCTD7 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of KCTD7 antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- KCTD7 (Potassium Channel Tetramerisation Domain Containing 7 (KCTD7))
-
Andere Bezeichnung
- KCTD7
-
Hintergrund
- The KCTD gene family, including KCTD7, encode predicted proteins that contain N-terminal domain that is homologous to the T1 domain in voltage-gated potassium channels. KCTD7 displays a primary sequence and hydropathy profile indicating intracytoplasmic localization. EST database analysis showed that KCTD7 is expressed in human and mouse brain.
-
Molekulargewicht
- 33 kDa (MW of target protein)
Target
-